期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CD4^＋CD25^＋调节性T细胞与肿瘤的相关性研究 被引量：6

CD4^＋CD25^＋ regulatory T cells and lung cancer
原文传递
导出
摘要 通过了解CD4^＋CD25^＋调节性T细胞（CD4^＋CD25^＋Treg）表面分子的特性和CD4^＋CD25^＋Treg在外周血和组织中的表达，认识CD4^＋CD25^＋Treg在肿瘤免疫调节中的作用，探索其作用的分子机制。 To know CD4^＋CD25^＋ regulatory T cells＇s function in tumor immunological regulation and to search for its functionary molecule mechanism by reviewing researches associated with the characteristics of CD4^＋CD25^＋ regulatory T ceils surface molecules and the expression of CD4^＋CD25^＋ regulatory T cells in the peripheral blood and tissues.
作者 翟晋芳(综述) 韩福才(审校)
机构地区 山西医科大学第二临床医学院研究生处 山西省肿瘤医院呼吸科
出处 《肿瘤研究与临床》 CAS 2009年第3期205-207,共3页 Cancer Research and Clinic
关键词 CD4^+CD25^+调节性T细胞 T因子转录因子 肿瘤 CD4^＋CD25^＋ regulatory T cells Cytokine Neoplasms
分类号 R392.11 [医药卫生—免疫学] R273-36 [医药卫生—中西医结合]
  • 相关文献

参考文献25

  • 1Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25. Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 1995, 155:1151-1164.
  • 2Vigouroux S, Yvon E, Biagi E, et al. Antigen-induced regula tory T cells. Blood, 2004, 104: 26-33.
  • 3Muller A J, Scherle PA. Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors. Nat Rev Cancer, 2006, 6: 613-625.
  • 4Khazaie K, Von Boehmer H. The impact of CD: CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer. Semin Cancer Biol, 2006, 16: 124-136.
  • 5Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD 4+ CD25+ regulatory T cells. Nat Immunol, 2003, 4: 330-336.
  • 6Kiniwa Y, Miyahara Y, Wang HY, et al. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res, 2007.13: 6947-6958.
  • 7Paust S, Lu L, McCarty N, et al. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A, 2004, 101: 10398-10403.
  • 8Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol, 2004, 4: 762-774.
  • 9Maloy KJ, Salaun L, Cahill R, et al, CD4+ CD25+ Treg suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med, 2003, 197: 111-119.
  • 10Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4+ CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor. J Exp Med, 2001, 194: 629-644.

二级参考文献2

  • 1王胜军,许化溪,杨胜利.CD4^+CD25^+调节性T细胞[J].细胞生物学杂志,2005,27(1):61-65. 被引量：20
  • 2Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance[ J]. Cell,2000,26(5 ) :455-458.

共引文献2

同被引文献72

  • 1Xiao-Xia Lu,Yi-Tian Chen,Bing Feng,Xiao-Bei Mao,Bo Yu,Xiao-Yuan Chu.Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma[J].World Journal of Gastroenterology,2013,19(12):1912-1918. 被引量：14
  • 2Suzuki E, Kapoor V, Jassar AS, et al. Gemcitabine selectively eliminates splenic Gr-I+/CD11b^+ myeloid suppressor cells in tumorbearing animals and enhances antitumor immune activity. Clin Cancer Res, 2005, 11:6713-6721.
  • 3Carreale P, Cusi MC, Tsang KY, et al. Chemoimmunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. J Clin Oncol, 2005, 23: 8950-8958.
  • 4Nowak AK, Lake RA, Robinson BW. Combined chemoimmunotherapy of solid tumours: improving vaccines? Adv Drug Deliv Rev, 2006, 58: 975-990.
  • 5Michel O, Theocharis P, Antoine T, et al. Leveraging the Immune System during Chemotherapy: Moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic. Cancer Res, 2007, 67: 7941-7944.
  • 6van der Most RG, Currie A J, Robinson BW, et al. Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all. Cell Death Differ, 2008, 15:13-20.
  • 7Rupal R, Scott A, Dmitry I, et al. Combined modality immunotherapy and chemotherapy: a new perspective. Cancer Immunol Immunother, 2008, 57: 1523-1529.
  • 8Lacour S, Hammann A, Wotawa A, et al. Anticancer agents sensitize tumor cells totumor necrosis factor-related apoptosis-inducing ligandmediated caspase-8 activation and apoptosis. Cancer Res, 2001, 61: 1645-1651.
  • 9Micheau O, Solary E, Hammann A, et al. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. J Natl Cancer Inst, 1997, 89: 783-789.
  • 10Ho MY, Sun GH, Leu S J, et al. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma. Int J Cancer, 2008, 123:123-133.

引证文献6

二级引证文献15

肿瘤研究与临床
2009年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部